EPIGENETICS & EMERGING OMICS STAGE

Rewriting Our Understanding Of Biology with Epigenetics, Emerging Omics & Population-Scale Studies

The Epigenetics & Emerging Omics Stage explores the complexities of epigenetics in health and disease states and investigates how epigenetics and other “omics” (such as metabolomics and lipidomics) can play a role in our understanding of and management of disease.

DAY 1


On Day 1, The Epigenetics & Emerging Omics Stage will focus on epigenetics and cancer epigenetics.

[topic] EPIGENETICS
-
Identifying Endocardial Cell Markers Using a Combined Transcriptomic and Epigenomic Strategy
  • This talk will cover how we’re using a combined transcriptomic and epigenomic approach to study endocardial cells markers from endocardial cells and heart valves.
  • We’ll showcase how we use both bulk and single cell approaches to identify novel biomarkers. We will also compare the methylomes of endocardial cells and endothelial cells using these methods.
  • Finally, we’ll show you how we’re using implementing this strategy to validate new candidate genes in an in vitro differentiation model using embryoid bodies. 
Speaker
Professor of Epigenetics
King's College London
-
More details to be announced shortly.

Sponsored by:


-
Deciphering the Genetics of Complex Traits Using Epigenomics
  • Gain insights into trait-associated genetic signals by mining epigenetic data across various tissues and cell types.
  • Identify causal cell-types, and genetic variants, and uncover potential drug targets through an epigenomic approach.
Speaker
Senior Computational Epigeneticist
Novo Nordisk
-
[break] Lunch
  • Exhibition Floor : Wander around the vibrant exhibition floor to see the latest technologies and services on offer
  • Food Options : Grab a sandwich at The Tree of Life Cafe or head on over to the Food Village for a range of hot food options including Indian, Jamaican and Thai food
  • Live Lounge Over Lunch : 15 mins technology focussed presentations
  • Poster Zone : Browse the posters and reach out to potential new collaborators
  • Talkaoke : The Flying Saucer of Chat, a fun and interactive pop-up show that offers you the opportunity to sit down with others and discuss any topic you like.
  • Patient Perspectives: Talks and discussions on the crucial role of patients and patient families in the understanding and development of treatments for rare diseases.
[topic] EPIGENETICS
-
Targeting Epigenetic Dysregulation in Paediatric Brain Tumours
  • Epigenetic regulation is crucial for brain development, ensuring precise control over cellular processes such as cell cycle progression and differentiation.
  • Aberrant epigenetic regulation significantly contributes to the development and progression of paediatric brain tumours, including medulloblastoma and high-grade glioma.
  • Reassessing and optimizing existing molecularly tailored therapies by targeting epigenetic drivers in stratified tumour subgroups is essential for improving treatment outcomes in paediatric brain tumours.
Speaker
Senior Lecturer
Queen Mary University of London
-
Combining epigenetic markers and mutation analyses for early multi-cancer detection
  • EpigenDx has uniquely designed multi-cancer sequencing panels
  • These panels assess both epigenetic biomarkers and actionable mutations in the same sequencing library
  • Simultaneous analysis of both data types increases the sensitivity and specificity for early cancer detection

Sponsored by:

Speaker
Scientist
EpigenDx
-
More Details to be announced shortly
-
[break] Break
  • Speed Networking: Fun and useful sessions where you’ll rapidly meet other Festival attendees to immediately expand your network.
  • Food Options : Grab a coffee and a cake at The Tree of Life Cafe or head on over to the Food Village for a range of hot food options including Indian, Jamaican and Thai food
  • Exhibition Floor : Wander around the vibrant exhibition floor to see the latest technologies and services on offer
  • Talkaoke : The Flying Saucer of Chat, a fun and interactive pop-up show that offers you the opportunity to sit down with others and discuss any topic you like.
[topic] CANCER EPIGENETICS
-
Sleepwalking Through Evolution: A Tale of Dormancy and Hormone Dependent Breast Cancer
  • Standard of care efficiently promote the transition to a dormant cell state
  • Transitions into dormancy and out of it are not driven by genetic events
  • We could potentially target the epigenetic drivers of these transitions
  • New technologies and models are needed if we want to eradicate dormant cells in patients.
Speaker
Professor and Lead, Breast Epigenetic Plasticity and Evolution Group
ICR
-
Sponsored Talk Available

-
Turning Anti-Viral Responses Against Cancer: Epigenetic and Epitranscriptomic Regulation of Anti-Viral Signaling in Cancer
  • Deciphering the role of non-coding nucleic acids in cancer
  • Turning Anti-viral responses against cancer using epigenetic therapies
  • Delineating the role of ADAR1-mediated RNA editing in cancer "
Speaker
Group Leader & PI, Ludwig Cancer Research
University of Oxford

DAY 2

Day 2 will focus on emerging omics (such as metabolomics and lipidomics) and epigenetics. The Epigenetics and Emerging Omics Stage will end with sessions on Population Genomics

[topic] EMERGING OMICS
-
Beyond Single Variant Analysis: Leveraging Multiomics in Liquid Biopsy for Cancer Detection
  • We developed the LIquid biopsy Fragmentation, Epigenetic signature, and Copy Number Alteration analysis (LIFE-CNA) method, employing Whole Genome Sequencing (WGS) to detect circulating tumour DNA (ctDNA) in colorectal cancer (CRC) patients.
  • This method serves as a diagnostic and monitoring tool for CRC detection and progression assessment. Building on our initial success, we have extended the applicability of the LIFE-CNA method to a diverse range of tumour entities, including prostate cancer, breast cancer, intraductal papillary mucinous neoplasms (IPMN), and Lynch Syndrome (LS)- associated cancers for LS patient surveillance.
  • Finally, we utilise multiomics approaches in other ongoing projects: one integrating transcriptome data with standard DNA diagnostics to enhance the detection of hereditary cancers and another employing nanopore long-read sequencing to characterise both epigenetic and genetic factors for diagnosing Facioscapulohumeral Muscular Dystrophy (FSHD), the third most common form of muscular dystrophy. "
Speaker
Co-lead R&D
MGZ Medical Genetics Center Munich
-
The Future of Spatial Single-Cell Metabolomics In The Fight Against Cancer And Infectious Diseases
  • Single-cell metabolomics is a powerful tool to study cellular biology at the greatest detail possible, giving insights into cell-cell interactions, lipids determining cell states and rapid phenotypic identification.
  • In this presentation, single-cell and sub-cellular analysis methods will be presented to aid researchers to understand what happens under defined conditions, and how cells signal to each other.
  • The power of these techniques will be demonstrated in understanding infectious diseases, ageing, cancers and how this can lead to novel treatments and vaccines
Speaker
Professor
University of Surrey
-
Lipidomics and Metabolomics for Rare Disease Diagnosis
  • Diagnostics to complement genomics
  • Biomarkers for diagnosis and understanding of disease
  • Monitoring response to therapy – Personalized medicine
Speaker
Professor in Mass Spectrometry, Biomedical Sciences
Swansea University
-
[break] Lunch
  • Exhibition Floor : Wander around the vibrant exhibition floor to see the latest technologies and services on offer
  • Food Options : Grab a sandwich at The Tree of Life Cafe or head on over to the Food Village for a range of hot food options including Indian, Jamaican and Thai food
  • Live Lounge Over Lunch : 15 mins technology focussed presentations
  • Poster Zone : Browse the posters and reach out to potential new collaborators
  • Talkaoke : The Flying Saucer of Chat, a fun and interactive pop-up show that offers you the opportunity to sit down with others and discuss any topic you like.
[topic] EPIGENETICS
-
More details to be announced shortly

-
More details to be announced shortly

Sponsored by: 


-
More details to be announced shortly

-
[break] Break
  • Speed Networking : Fun and useful sessions where you’ll rapidly meet other Festival attendees to immediately expand your network.
  • Food Options : Grab a coffee and a cake at The Tree of Life Cafe or head on over to the Food Village for a range of hot food options including Indian, Jamaican and Thai food
  • Exhibition Floor : Wander around the vibrant exhibition floor to see the latest technologies and services on offer
  • Talkaoke : The Flying Saucer of Chat, a fun and interactive pop-up show that offers you the opportunity to sit down with others and discuss any topic you like.
[topic] POPULATION GENOMICS
-
Leveraging Population Genomics for Drug Discovery
  • How large scale population genomics studies are informing drug discovery and translational approaches.
  • How these studies provide vital insights to disease mechanisms, patient risk and prediction of responses.
  • How can the identfication of novel disease associated variants inform precision medicine approaches. "
Speaker
Associate Principal Clinical Genomics Scientist
AstraZeneca
-
The Missing Ancestry Problem: Why We’re Still Failing in Genomic Diversity
  • Lack of diverse representation in datasets contributes to inequities in healthcare, perpetuating biases for patients with underrepresented ancestral backgrounds
  • Global data bias ancestry representation is systemic across genomic research and reference databases, including genome wide association studies (GWAS), pharmacogenomics, clinical trials, and direct-to-consumer (DTC) genetic testing
  • Relative proportions for ancestries represented in datasets, compared to the global census population, render insufficient equity in representative sampling of global diversity to reflect the genomic diversity present in world populations
  • Strategic inclusion, and effective mechanisms to ensure representation of global genomic diversity in datasets are imperative 
Speaker
Lecturer in Genomics
University of Westminster